These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6573138)

  • 1. Aspirin therapy in vernal conjunctivitis.
    Abelson MB; Butrus SI; Weston JH
    Am J Ophthalmol; 1983 Apr; 95(4):502-5. PubMed ID: 6573138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of combined systemic aspirin and cromolyn sodium in intractable vernal catarrh.
    Chaudhary KP
    Ann Ophthalmol; 1990 Aug; 22(8):314-8. PubMed ID: 2121083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conjunctival hyperresponsiveness to ocular histamine challenge in patients with vernal conjunctivitis.
    Bonini S; Bonini S; Schiavone M; Centofanti M; Allansmith MR; Bucci MG
    J Allergy Clin Immunol; 1992 Jan; 89(1 Pt 1):103-7. PubMed ID: 1730830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased production of prostaglandin D2 in patients with systemic mastocytosis.
    Roberts LJ; Sweetman BJ; Lewis RA; Austen KF; Oates JA
    N Engl J Med; 1980 Dec; 303(24):1400-4. PubMed ID: 6107852
    [No Abstract]   [Full Text] [Related]  

  • 5. The flush syndrome: an expression of systemic mastocytosis with increased prostaglandin D2 production.
    Kootte AM; Haak A; Roberts LJ
    Neth J Med; 1983; 26(1):18-20. PubMed ID: 6572798
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of antiprostaglandin therapy in vernal conjunctivitis.
    Meyer E; Kraus E; Zonis S
    Br J Ophthalmol; 1987 Jul; 71(7):497-9. PubMed ID: 3115287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on histamine and histaminase in spring catarrh (vernal conjunctivitis).
    Mukhopadhyay K; Pradhan SC; Mathur JS; Gambhir SS
    Int Arch Allergy Appl Immunol; 1981; 64(4):464-8. PubMed ID: 6782024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant therapy of aspirin and cromoglycate 2% eye drops in vernal conjunctivitis.
    Srinivas C
    Korean J Ophthalmol; 1989 Jun; 3(1):42-6. PubMed ID: 2507808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical antihistamines and mast cell stabilisers for treating seasonal and perennial allergic conjunctivitis.
    Castillo M; Scott NW; Mustafa MZ; Mustafa MS; Azuara-Blanco A
    Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD009566. PubMed ID: 26028608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of vernal conjunctivitis with aspirin].
    Lemrini F; Dafrallah L; Sebbahi F; Rafi M
    Rev Int Trach Pathol Ocul Trop Subtrop Sante Publique; 1989; 66(3-4):119-27. PubMed ID: 2488658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium cromoglycate (intal) in the treatment of vernal keratoconjunctivitis and allergic conjunctivitis.
    Kazdan JJ; Crawford JS; Langer H; MacDonald AL
    Can J Ophthalmol; 1976 Oct; 11(4):300-3. PubMed ID: 824033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tear histamine levels in vernal conjunctivitis and other ocular inflammations.
    Abelson MB; Baird RS; Allansmith MR
    Ophthalmology; 1980 Aug; 87(8):812-4. PubMed ID: 7443214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mast cell-dependent immediate hypersensitivity responses.
    Lewis RA
    Prog Clin Biol Res; 1986; 213():457-70. PubMed ID: 3086897
    [No Abstract]   [Full Text] [Related]  

  • 14. Bepotastine besilate, a highly selective histamine H(1) receptor antagonist, suppresses vascular hyperpermeability and eosinophil recruitment in in vitro and in vivo experimental allergic conjunctivitis models.
    Kida T; Fujii A; Sakai O; Iemura M; Atsumi I; Wada T; Sakaki H
    Exp Eye Res; 2010 Jul; 91(1):85-91. PubMed ID: 20412793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tear and serum soluble leukocyte activation markers in conjunctival allergic diseases.
    Leonardi A; Borghesan F; Faggian D; Depaoli M; Secchi AG; Plebani M
    Am J Ophthalmol; 2000 Feb; 129(2):151-8. PubMed ID: 10682966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Allergic conjunctivitis in children].
    Zepeda Ortega B; Rosas Vargas MA; Ito Tsuchiya FM; del Río Navarro BE; Sienra Monge JJ
    Rev Alerg Mex; 2007; 54(2):41-53. PubMed ID: 17542245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The release and role of inflammatory mediators in asthma.
    Holgate ST; Robinson C; Church MK; Howarth PH
    Clin Immunol Rev; 1985; 4(2):241-88. PubMed ID: 2417772
    [No Abstract]   [Full Text] [Related]  

  • 18. Prolonged effectiveness of bepotastine besilate ophthalmic solution for the treatment of ocular symptoms of allergic conjunctivitis.
    Williams JI; Kennedy KS; Gow JA; Torkildsen GL; Abelson MB; Gomes PJ; McNamara TR;
    J Ocul Pharmacol Ther; 2011 Aug; 27(4):385-93. PubMed ID: 21649522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of prostaglandins in allergic inflammation].
    Rasković S; Bogić M; Perić-Popadić A; Arandjelović S; Jovcić Z; Tomić-Spirić V
    Srp Arh Celok Lek; 1998; 126(9-10):388-93. PubMed ID: 9863413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percentage of degranulated mast cells in vernal conjunctivitis and giant papillary conjunctivitis associated with contact-lens wear.
    Allansmith MR; Baird RS
    Am J Ophthalmol; 1981 Jan; 91(1):71-5. PubMed ID: 7234932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.